iX Biopharma Ratios and Metrics

Market cap in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 9, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	349	14	22	70	122	167
Market Cap Growth	2082.15%	-36.24%	-68.05%	-43.05%	-26.84%	3.17%
Enterprise Value	338	17	22	62	111	162
PS Ratio	49.82	1.83	3.74	11.79	8.51	95.91
PB Ratio	20.52	38.92	5.13	4.40	6.20	14.29
P/TBV Ratio	20.84	149.55	5.51	4.48	6.31	14.81
P/FCF Ratio	-	-	-	-	41.89	-
P/OCF Ratio	-	-	-	-	39.21	-
EV/Sales Ratio	48.31	2.20	3.73	10.51	7.70	92.74
EV/EBITDA Ratio	-	-	-	-	96.40	-
EV/EBIT Ratio	-	-	-	-	221.09	-
EV/FCF Ratio	-58.34	-	-	-	37.89	-
Debt / Equity Ratio	0.35	16.17	1.20	0.27	0.22	0.36
Debt / EBITDA Ratio	-	-	-	-	2.91	-
Debt / FCF Ratio	-	-	-	-	1.51	-
Net Debt / Equity Ratio	-0.62	13.61	0.77	-0.14	-0.46	-0.17
Net Debt / EBITDA Ratio	1.87	-0.85	-0.47	0.24	-7.99	0.18
Net Debt / FCF Ratio	1.83	-1.25	-0.49	0.26	-3.14	0.22
Asset Turnover	0.36	0.60	0.30	0.22	0.61	0.10
Inventory Turnover	5.13	4.98	4.21	3.86	2.09	2.14
Quick Ratio	2.14	0.32	0.65	1.34	1.98	2.19
Current Ratio	2.31	0.47	0.89	1.53	2.14	2.55
Return on Equity (ROE)	-53.78%	-431.07%	-106.91%	-54.02%	-29.23%	-75.27%
Return on Assets (ROA)	-19.32%	-30.32%	-23.69%	-22.32%	1.32%	-39.86%
Return on Capital Employed (ROCE)	-31.80%	-272.70%	-103.50%	-53.80%	2.40%	-75.20%
Earnings Yield	-1.34%	-71.38%	-48.44%	-13.79%	-3.75%	-4.92%
FCF Yield	-1.66%	-27.87%	-30.64%	-11.98%	2.39%	-5.32%
Buyback Yield / Dilution	-7.68%	-14.25%	-0.33%	-2.51%	-7.60%	-7.13%